Dosing: Adult
Brucellosis: I.M.: 1 g/day for 14-21 days (with doxycycline, 100 mg twice daily for 6 weeks)
Endocarditis: I.M.:
Enterococcal: 1 g every 12 hours for 2 weeks, 500 mg every 12 hours for 4 weeks in combination with penicillin
Streptococcal: 1 g every 12 hours for 1 week
Mycobacterium avium complex: I.M.: Adjunct therapy (with macrolide, rifamycin, and ethambutol): 15 mg/kg 3 times/week for first 2-3 months for severe disease
Plague: I.M.: 15 mg/kg (or 1 g) every 12 hours until the patient is afebrile for at least 3 days
Tuberculosis: I.M.:
Daily therapy: 15 mg/kg/day (maximum: 1 g)
Directly observed therapy (DOT), twice weekly: 25-30 mg/kg (maximum: 1.5 g)
Directly observed therapy (DOT), 3 times/week: 25-30 mg/kg (maximum: 1.5 g)
Tularemia: I.M.: 10-15 mg/kg every 12 hours (maximum: 2 g/day) for 7-10 days or until patient is afebrile for 5-7 days
Dosing: Pediatric
(For additional information see "Streptomycin: Pediatric drug information")
Tuberculosis: I.M.:
Daily therapy: 20-40 mg/kg/day (maximum: 1 g/day)
Directly observed therapy (DOT), twice weekly: 25-30 mg/kg (maximum: 1.5 g)
Directly observed therapy DOT, 3 times/week: 25-30 mg/kg (maximum: 1.5 g)
Dosing: Geriatric
I.M.: 10 mg/kg/day, not to exceed 750 mg/day; dosing interval should be adjusted for renal function. Some authors suggest not to give more than 5 days/week or give as 20-25 mg/kg/dose twice weekly.
Dosing: Renal Impairment
Clcr 10-50 mL/minute: Administer every 24-72 hours.
Clcr <10 mL/minute: Administer every 72-96 hours.
Removed by hemo- and peritoneal dialysis: Administer dose postdialysis
| Streptomycin More info | |
|---|---|
| Mode Of Action | irreversibly binds to 30s sub-unit of bacterial ribosomes; blocks recognition step in protein synthesis and causes growth inhibition. |
| Drug Indication | Streptomycin sensitive infections; TB. |
| Precautions | Possible drug resistant, impaired renal/hepatic functions, myasthenia gravis, administration of other ototoxic agents. |
| Contra-Indications | Allergy to streptomycin, pregnancy, ear diseases. |
| Side Effects | Ototoxicity, tinnitus, allergic reactions, anaphylactic reactions, headache, neuromuscular block and respiratory arrest with peritoneal cavity administration, nausea, ataxia. |
| Dosage | 1g or 15mg/kg IM daily (to a maximum of 120g in treatment course). Advised dose in geriatric is 10mg/kg daily. |
| Pregnancy Category | Category D |
| Pregnancy Category Description | Drugs, which have caused, are suspected to have caused, or may be expected to cause an increased rise in the frequency of malformations or irreversible damage. These drugs may also have adverse pharmacological effects required required |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Anti-Tuberculous Drugs |
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Streptomycin, | Dawa Limited | Dawa Limited | 1g | 1 | Injection | per vial | KES 18.00 |